Prime moves up on Inc. Magazine’s Annual List of America’s Fastest-Growing Private Companies

For the 8th consecutive year, Prime appears on the Inc. 5000, ranking no. 1,073 with three-year revenue growth of 391 percent

August 14, 2019
Prime Therapeutics (Prime) improved its standing by more than 200 places – from 1,288 in 2018 to 1,073 in 2019 – in the 38th annual Inc. 5000, a ranking of the nation’s fastest-growing private companies by Inc. Magazine. This is the eighth straight year Prime has achieved this distinction. And since 2017 Prime has been part of a select group of companies on Inc. 5000’s “Honor Roll.” Fewer than a tenth of Inc. 5000 honorees to ever achieve this milestone.

The list includes the most successful American companies in the dynamic independent small businesses segment. Companies that made the list, on average, have grown six-fold since 2015.

“In a rapidly consolidating market, our superior partnership model is helping to drive consistent growth among our existing clients, new clients, and new markets,” said Rob Kelley, interim chief financial officer at Prime. “We should all be extremely proud of these results and understand that continued commitment to consumer-centric innovation and total drug management will continue to help us grow and climb in this ranking.”

The full list, including Prime’s company profile, is available and will publish in the September issue of Inc., a leading publication for entrepreneurs.

Related news

Stories

April 5, 2024

LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast

In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.

Stories

March 26, 2024

Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits

Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…

Stories

March 19, 2024

Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars 

Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry